PTX
Click for more information
2.44% 4.2¢ prescient therapeutics limited

Ann: FDA grants broader orphan drug status to PTX100 for TCLs, page-9

  1. slrpnk
    2 Posts.
    lightbulb Created with Sketch. 4
    clock Created with Sketch.
    09/03/23
    10:45
    Post #: 66672969
    Looks like FDA is already bullish on PTX-100 - "granting broader designation than Prescient requested". Bodes well for its chances on getting on the Accelerated Approval Program this year that SYC alluded to - all eyes on the update of the Phase1b study.
    PTX Price at posting: 12.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 29  Upvote
    lightbulb Created with Sketch. 4  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AUN Aurumin reports high-grade iron ore rock chips at Central Sandstone, WA
right-arrow Created with Sketch.
ASL Andean discovers up to 4,649 AgEq through maiden drilling in Chile
right-arrow Created with Sketch.
IVR Investigator Resources hits 8m @ 1.06% copper on-site Stuart Shelf JV project acreage
right-arrow Created with Sketch.
ENR Encounter sniffs 4% niobium across 1.6km of strike in WA
right-arrow Created with Sketch.
HIQ HITIQ's sensor-containing mouthguard OK'd by World Rugby specifications board
right-arrow Created with Sketch.
M2R Miramar sniffs 5.48% Cu, 54.4% Pb and 73.48g/t Ag at new WA prospect
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢ 		Change
0.001(2.44%) 		Mkt cap ! $33.82M
Open High Low Value Volume
4.2¢ 4.3¢ 4.1¢ $23.91K 563.5K

Buyers (Bids)

No. Vol. Price($)
1 70733 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 24822 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.